Sex differences in determinants of COVID-19 severe outcomes – findings from the National COVID Cohort Collaborative (N3C)Article Published on 2022-10-122022-11-15 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-022-07776-7 PMC 바로가기
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernArticle Published on 2022-10-012022-11-15 Journal: ESMO open [Category] [DOI] 10.1016/j.esmoop.2022.100574 PMC 바로가기
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in IndiaArticle Published on 2022-09-222022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0274089 PMC 바로가기
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study고형암 환자에서 SARS-CoV-2 백신접종에 대한 혈청학적 반응에 영향을 미치는 요인: 전향적 연구Observational Study Published on 2022-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] [DOI] 10.1016/j.jiac.2022.05.021 PMC 바로가기 [Article Type] Observational Study
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies혈액암이 있는 성인 환자의 SARS-CoV-2 백신 1차 및 2차 접종에 대한 면역 반응의 체계적인 검토 및 메타 분석Review Published on 2022-09-012022-09-11 Journal: International immunopharmacology [Category] [DOI] 10.1016/j.intimp.2022.109046 PMC 바로가기 [Article Type] Review
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile칠레의 면역 저하 환자 집단에서 비활성화된 중증 급성 호흡기 증후군 코로나바이러스 2 백신에 대한 면역 반응 감소Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac167 PMC 바로가기 [Article Type] Article
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)광범위한 면역 손상 조건에 걸친 코로나바이러스 질병 2019(COVID-19) 백신 반응의 전향적 평가: 면역 손상 연구(COVICS)의 COVID-19 백신 접종Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac103 PMC 바로가기 [Article Type] Article
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results Research Published on 2022-08-152022-10-05 Journal: Nature Medicine [Category] [DOI] 10.1038/s41591-022-01937-6 [Article Type] Research
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccinesmRNA 백신 추가 접종 후 활성 요법을 받는 암 환자의 SARS-CoV-2 감염Article Published on 2022-08-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] [DOI] 10.1016/j.ejca.2022.05.018 PMC 바로가기 [Article Type] Article
Single-cell sorting based on secreted products for functionally defined cell therapies Reviews Published on 2022-07-222022-10-05 Journal: Microsystems & Nanoengineering [Category] [DOI] 10.1038/s41378-022-00422-x [Article Type] Reviews